Hi everyone. I am a new poster and came across the topic of Sirna. I’ve done a little research on this topic and thought I would share a bit if anyone is interested.
Sirna is a publicly traded company on the stock exchange so if you were to go to say “yahoo” (I hope I can name another website) and go to their finance section and put in their ticker symbol (RNAI), you can read about the company and any news that is coming out about their work etc.
I’ve read a few posts regarding gene therapy and the dangers involved. siRNA (short interfering RNA) is not gene therapy per se. With gene therapy you are removing a defective gene and replacing with a non defective one or you are trying to fix the defective gene in some way shape or form. This is dangerous because of possible damage to other genes etc.
With siRNA technology (this is not something new. There are a number of biotech companies that are investigating different therapies from macular degeneration to huntingtons disease), you are not messing with the gene, you are only blocking the messenger RNA from making a certain protein.
I look at it this way. Take two people, and place them on opposite sides of a room. Person A has a flashlight which would represent the gene and the beam of light representing the messenger RNA. If person flashes a beam of light at person B it causes person B to react (which would represent the cell making a protein). If a piece of paper (representing siRNA) blocks the beam of light, the message does not get to where it needs to go. The flashlight (gene) has not been modified, its message just doesn’t get to where it needs to go…ie, the protein is not made by the cell.
This product will be administered by a doctor. I believe the reason for this is simply liability. Some people have no problems reading the directions on the side of a prescription bottle…others do. Could you imagine if this was sold over the counter or even given out by prescription? I have heard stories of people going to a party, passing out and having friends nair their eyebrows. Well, I think you can see where I am going with this.
The product (Trichozyme)is suspended in an alcohol base which is then placed on the skin. I am guessing the alcohol helps with absorbtion in to the hair follicle a lot easier than a thick cream. Sirna has so far done in vitro and in vivo studies to prove the product makes it in to the hair follicle cells. This is very important. A major headache for siRNA researchers for other ailments has been the delivery mode. Cells do not readily take up RNA. When they have RNA knocking on their door they automatically “think” virus. This must not be a problem for this product.
From what I have read, they expect to start human trials in 2006 and will have a product for general public use by 2011.
I hope some of this was helpful. Again, this is just research I have done, so things could change.
jme